EBITDA: Income before interest, taxes, depreciation and amortization.
Abbott Laboratories (ABT) EBITDA data is not available for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$9.96B |
|
$1.23B |
|
$4.46B |
|
$5.50B |
|
$8.58B |
|
$1.39B |
|
$50.00M |
|
$1.44B |
|
$1.44B |
|
$1.23B |
|
$1.23B |
|
$1.23B |
|
$1.23B |
|
$1.39B |
|
|
EBITDA |
-- |
-- |
|
1.75B |
|
-- |
|
$0.70 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|